Stock CRVO CERVOMED INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus CervoMed Inc.

Equities

CRVO

US15713L1098

Market Closed - Nasdaq
Other stock markets
 01:30:00 26/06/2024 am IST 		5-day change 1st Jan Change
20 USD 0.00% Intraday chart for CervoMed Inc. +7.24% +162.12%
11/06 CervoMed Inc. Announces Completion of Enrollment in Phase 2b RewinD-LB Clinical Trial of Neflamapimod for the Treatment of Patients with Dementia with Lewy Bodies CI
29/05 JonesTrading Starts CervoMed With Buy Rating, $70 Price Target MT

Evolution of the average Target Price on CervoMed Inc.

Price target over the last 5 years

History of analyst recommendation changes

41f318367f3bab581a.MbYhhpskYsXNYQ42YT1GNjeGJbIkng_Ib2DKiGH5q9Q.A9tE6_lcGKf9DUpfJ1VxQ1P8CPNcz1WyAjbzuFS64qxfgHTzrUxPoJxMbQ~9b07b1d49f9ac68ed6205c1fd3276f57

Analyst Recommendations on CervoMed Inc.

JonesTrading Starts CervoMed With Buy Rating, $70 Price Target MT
Canaccord Genuity Adjusts Price Target on CervoMed to $65 From $50, Maintains Buy Rating MT
Canaccord Genuity Starts CervoMed With Buy Rating, $50 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
20 USD
Average target price
55 USD
Spread / Average Target
+175.00%
High Price Target
70 USD
Spread / Highest target
+250.00%
Low Price Target
30 USD
Spread / Lowest Target
+50.00%

Consensus detail

Consensus revision (last 18 months)

Analysts covering CervoMed Inc.

JonesTrading Institutional Services
Canaccord Genuity

Ratings for CervoMed Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CRVO Stock
  4. Consensus CervoMed Inc.